scPharmaceuticals Ownership | Who Owns scPharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

scPharmaceuticals Ownership Summary


scPharmaceuticals is owned by 69.51% institutional investors, 6.02% insiders, and 24.47% retail investors. Orbimed advisors is the largest institutional shareholder, holding 11.28% of SCPH shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.26% of its assets in scPharmaceuticals shares.

SCPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockscPharmaceuticals69.51%6.02%24.47%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbimed advisors6.06M11.28%$23.09M
Rubric capital management lp4.78M10.26%$16.90M
Aigh capital management3.87M7.20%$14.74M
King luther capital management3.54M6.59%$13.49M
Blackrock1.77M4.54%$7.69M
Vanguard group2.11M4.53%$7.46M
Blackrock funding, inc. /de2.21M4.12%$8.43M
Rice hall james & associates1.47M2.74%$5.61M
5am venture management1.20M2.58%$4.25M
Ubs group1.04M2.23%$3.67M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aigh capital management3.87M6.63%$14.74M
Apis capital advisors752.00K1.02%$2.87M
5am venture management1.20M1.01%$4.25M
Tejara capital497.73K0.88%$1.90M
Orbimed advisors6.06M0.58%$23.09M
Kingdon capital management659.71K0.34%$2.51M
Rice hall james & associates1.47M0.30%$5.61M
Balanced rock investment advisor90.97K0.27%$346.59K
Rubric capital management lp4.78M0.22%$16.90M
Nantahala capital management995.44K0.15%$3.79M

Top Buyers

HolderShares% AssetsChange
Ubs group1.04M0.00%1.02M
King luther capital management3.54M0.06%420.00K
Vanguard group2.11M0.00%399.51K
Goldman sachs group409.46K0.00%334.69K
Apis capital advisors752.00K1.02%247.05K

Top Sellers

HolderShares% AssetsChange
Suvretta capital management---1.84M
Velan capital investment management lp---517.67K
J. goldman & co lp121.50K0.01%-464.74K
Bank of montreal /can/---351.81K
Stonepine capital management---347.69K

New Positions

HolderShares% AssetsChangeValue
Pale fire capital se57.13K0.02%57.13K$217.66K
Hrt financial lp40.67K0.00%40.67K$154.00K
Los angeles capital management28.67K0.00%28.67K$109.23K
Price t rowe associates inc /md/15.14K-15.14K$54.00K
Colony group12.92K0.00%12.92K$49.24K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-6.00
Farther finance advisors-59.00
Capital performance advisors llp-85.00
Covestor-151.00
Gamma investing-265.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20259910.00%37,340,2231.22%691.47%4916.67%3214.29%
Mar 31, 20256-93.10%8,173,062-79.45%180.25%2-96.30%2-87.50%
Dec 31, 202482-16.33%39,015,4824.73%831.31%49-19.67%16-15.79%
Sep 30, 20249721.25%37,237,61933.87%791.57%6046.34%19-20.83%
Jun 30, 202479-2.47%27,815,2484.03%711.50%4117.14%23-23.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.14M2.26%-
Vanguard Total Stock Mkt Idx Inv1.11M2.09%-24.58K
iShares Russell 2000 ETF830.25K1.57%-15.75K
Fidelity Small Cap Index400.50K0.76%-8.30K
iShares Russell 2000 Growth ETF318.56K0.60%-
Vanguard Institutional Extnd Mkt Idx Tr290.04K0.54%-116.07K
Kennedy Micro Cap218.81K0.44%1.05K
State St Russell Sm/Mid Cp® Indx SL Cl I229.05K0.43%-
State St Russell Sm/Mid Cp® Indx NL Cl C212.85K0.42%-
Thrivent Moderately Aggressive Allc174.37K0.33%383.00

Recent Insider Transactions


DateNameRoleActivityValue
Aug 13, 2024ORBIMED ADVISORS LLC-Buy$86.63K
Aug 13, 2024ORBIMED ADVISORS LLC-Buy$1.91M
Nov 25, 2022ORBIMED ADVISORS LLC-Buy$4.00M
Oct 06, 20225AM Partners IV, LLC-Sell$152.89K
Oct 06, 2022Schwab Andrew J.-Sell$152.89K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q32-
2024 Q2--
2024 Q1--

SCPH Ownership FAQ


Who Owns scPharmaceuticals?

scPharmaceuticals shareholders are primarily institutional investors at 69.51%, followed by 6.02% insiders and 24.47% retail investors. The average institutional ownership in scPharmaceuticals's industry, Biotech Stocks , is 306.59%, which scPharmaceuticals falls below.

Who owns the most shares of scPharmaceuticals?

scPharmaceuticals’s largest shareholders are Orbimed advisors (6.06M shares, 11.28%), Rubric capital management lp (4.78M shares, 10.26%), and Aigh capital management (3.87M shares, 7.20%). Together, they hold 28.74% of scPharmaceuticals’s total shares outstanding.

Does Blackrock own scPharmaceuticals?

Yes, BlackRock owns 4.54% of scPharmaceuticals, totaling 1.77M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.69M$. In the last quarter, BlackRock decreased its holdings by -32.941K shares, a -1.83% change.

Who is scPharmaceuticals’s biggest shareholder by percentage of total assets invested?

Aigh capital management is scPharmaceuticals’s biggest shareholder by percentage of total assets invested, with 6.63% of its assets in 3.87M scPharmaceuticals shares, valued at 14.74M$.

Who is the top mutual fund holder of scPharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of scPharmaceuticals shares, with 2.26% of its total shares outstanding invested in 1.14M scPharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools